Stem cells to optimize match between patient and medication

One of the biggest barriers to the development of new medical therapies is the cost of taking a new drug from a concept in a lab to a proven treatment. Estimates of these costs range from $100-million to $1.2-billion for each new drug that makes it to market, and a substantial chunk of this funding is consumed by establishing that a drug is both safe and effective. A new initiative combining breakthroughs in research, private sector support, and a non-profit committed to regenerative medicine is dedicated to improving this process.

View the original article here: Stem cells to optimize match between patient and medication – National Post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: The evolutionary history of the COVID-19 coronavirus

Infographic: The evolutionary history of the COVID-19 coronavirus

Reuters analysed over 185,000 genome samples from the Global Initiative on Sharing All influenza Data (GISAID), the largest database of ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend